Renoprotective Effects of Various Angiotensin II Receptor Blockers in Patients with Early-Stage Diabetic Nephropathy | Zendy

Tsukasa Nakamura | Zendy; Nobuharu Fujiwara | Zendy; Eiichi Sato | Zendy; Yoshihiko Ueda | Zendy; Takeshi Sugaya | Zendy; Hikaru Koide | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Renoprotective Effects of Various Angiotensin II Receptor Blockers in Patients with Early-Stage Diabetic Nephropathy

Author(s) -

Tsukasa Nakamura,

Nobuharu Fujiwara,

Eiichi Sato,

Yoshihiko Ueda,

Takeshi Sugaya,

Hikaru Koide

Publication year - 2010

Publication title -

kidney and blood pressure research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.806

H-Index - 51

eISSN - 1423-0143

pISSN - 1420-4096

DOI - 10.1159/000316707

Subject(s) - olmesartan , losartan , candesartan , telmisartan , microalbuminuria , medicine , endocrinology , diabetic nephropathy , creatinine , nephropathy , angiotensin ii , excretion , renal function , angiotensin receptor , blood pressure , diabetes mellitus

There is increasing evidence that inhibition of the renin-angiotensin system provides renoprotection independent of blood pressure lowering. The aim of the present study was to determine whether various angiotensin II receptor blockers (ARBs) affect urinary albumin excretion (UAE), urinary liver-type fatty acid-binding protein (L-FABP) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels in early-stage diabetic nephropathy patients with microalbuminuria.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research